Abstract
The infection with SARS-CoV-2 is reported to be accompanied by the shedding of the virus in stool samples of infected patients. Earlier reports have suggested that COVID-19 agents can be present in the fecal and sewage samples and thus it can be a good indication of the pandemic extent in a community. However, no such studies have been reported in the Indian context so far. Since, several factors like local population physiology, the climatic conditions, sewage composition, and processing of samples could possibly affect the detection of the viral genome, it becomes absolutely necessary to check for the presence of the SARS-CoV-2 in the wastewater samples from wastewater treatment plants (WWTPs) serving different localities of Jaipur city, which has been under red zone (pandemic hotspots) since early April 2020. Samples from different local municipal WWTPs and hospital wastewater samples were collected and wastewater based epidemiology (WBE) studies for the presence of SARS-CoV-2 were carried out using the RT-PCR technique to confirm the presence of different COVID-19 target genes namely S gene, E gene, ORF1ab gene, RdRp gene and N gene in the viral load of wastewater samples. In the present study, the untreated wastewater samples from the municipal WWTPs and hospital wastewater samples showed the presence of SARS-CoV-2 viral genome, which was correlated with the increased number of COVID-19 positive patients from the concerned areas, as per reported in the publically available health data. This is the first study that investigated the presence of SARS-CoV-2 viral genome in wastewater, at higher ambient temperature (above 40°C), further validating WBE as a potential tool in predicting and mitigating outbreaks.
Highlights
The study reports detection of SARS-CoV-2 in sewage in India.
The presence of SARS-CoV-2 was confirmed by RT-PCR.
The presence of viral genome was detected at high ambient temperatures of 40-45° C.
Corroborates trends in the WWTPs showing viral genome with public health data.
Treated effluent from WWTPs appears safe for reuse with low public health concern.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The present work was not funded by any external funding agency and all funds were incurred by the institute Dr. B. Lal Institute of Biotechnology, Jaipur.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The present research work has received ethical clearance from Institutional Ethics Committee (IEC). The work does not include clinical trials.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
sudiptiarora{at}gmail.com
aditinag1{at}gmail.com
jasmine{at}blalbiotech.com
jayana{at}blalbiotech.com
Sonika{at}blalbiotech.com
ssk.cird1{at}gmail.com
abgupta.ce{at}mnit.ac.in
Data Availability
Authors will submit the data, as & when required.
